Vymada Tablet is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure (New York Heart Association Class II-IV) and reduced ejection fraction. VYMADA 100MG TABLET contains a combination of sacubitril and valsartan, available as a film-coated tablet for oral use.
Before taking Vymada Tablet, inform your doctor if you have liver, kidney, or heart problems. It is not recommended for use in pregnant and breast-feeding women. This medicine is not suitable for use in children and adolescents under 18 years of age, and it should be used with caution in elderly patients (65 years of age and above).
Before taking Vymada Tablet, inform your doctor about previous allergies and medication history to manage any serious effects. Common side effects of taking this medicine are dizziness, cough, headache, tiredness, nausea, and weakness. Consult your doctor if any of the side effects worsen.
No content available
